EDIT vs SNOW · rev $32.3M vs rev $4.68B
Editas Medicine Inc (EDIT) versus Snowflake Inc. (SNOW) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Snowflake Inc. (SNOW) is a software - application company listed on US. It is led by Sridhar Ramaswamy.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported SNOW revenue for 2026-01-31 was $4.68B. Net income was -$1.33B. Revenue was up 29.2% from 2025-01-31 to 2026-01-31. SNOW currently screens at market cap $73.90B.
EDIT currently screens at market cap $375.2M. SNOW currently screens at market cap $73.90B.
Not investment advice. Open the EDIT and SNOW stock pages for the full models.
Not investment advice.